Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids
about
Marijuana: current concepts(†)Gone to Pot - A Review of the Association between Cannabis and PsychosisMarijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalizationDistinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?High times, low sats: diffuse pulmonary infiltrates associated with chronic synthetic cannabinoid use.Synthetic marijuana "K2" induced ITP.Rapid analysis of forensic-related samples using two ambient ionization techniques coupled to high-resolution mass spectrometers.Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in MiceSpice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis.Motor vehicle collisions caused by the 'super-strength' synthetic cannabinoids, MAM-2201, 5F-PB-22, 5F-AB-PINACA, 5F-AMB and 5F-ADB in Japan experienced from 2012 to 2014.The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.Sulfaphenazole and α-naphthoflavone attenuate the metabolism of the synthetic cannabinoids JWH-018 and AM2201 found in K2/spice.Synthetic cannabinoid use among patients in residential substance use disorder treatment: prevalence, motives, and correlates.A 'spicy' encephalopathy: synthetic cannabinoids as cause of encephalopathy and seizureMetabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry.New drugs of abuse.The hallucinogenic world of tryptamines: an updated review.Baths salts, spice, and related designer drugs: the science behind the headlines.Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with humComparison of outcome expectancies for synthetic cannabinoids and botanical marijuana.Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization.Using cheminformatics to predict cross reactivity of "designer drugs" to their currently available immunoassays.Synthetic Cannabinoids: Use and Predictors in a Community Sample of Young Adults.Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.Rapid screening of 35 new psychoactive substances by ion mobility spectrometry (IMS) and direct analysis in real time (DART) coupled to quadrupole time-of-flight mass spectrometry (QTOF-MS).Rapid analysis of synthetic cannabinoids using a miniature mass spectrometer with ambient ionization capabilityMetabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS.K2 and Spice use among a cohort of college students in southeast region of the USA.Hemorrhagic stroke following use of the synthetic marijuana "spice".Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific maIn Vitro and In Vivo Human Metabolism of Synthetic Cannabinoids FDU-PB-22 and FUB-PB-22.The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation.Self-Administration of an Endogenous Cannabinoid 2-Arachidonoylglycerol in Experimentally Naïve RatsSelf-Administration of JWH-018 A Synthetic Cannabinoid in Experimentally Naïve Rats
P2860
Q21090461-770CD386-B85C-463E-8424-789E4256F236Q26865311-2A66A60A-E71B-42CA-9E80-3AB85280854FQ27009287-F760D228-2B4C-495A-9845-5802C4CCF7B7Q28540537-B9A220E5-6F7E-4AC5-98A6-9B7345A86E63Q33162567-438A5F2C-6FA5-4052-B7A4-27C52D74072FQ33414731-6C149397-4A15-4F46-833A-3DE6AD03464BQ33469963-2950CF98-1333-4F58-A45A-215D7721C51AQ33583810-FA9AF24F-D52F-48CF-885F-3EF447E3CFABQ33655795-E5F9338B-3575-4536-85DD-D6CB9AED31D1Q33841041-A915DB0A-CDD3-483B-9AB4-8862DA17E5DEQ33908169-C56C1E83-27BF-442A-B20D-BF1C5C0572C3Q34133537-8C5D95A7-E194-46DA-A64D-7418854219BCQ34167511-7C1CB748-43BD-42EF-B1C8-01843A4CA2EBQ34364919-6C42775B-71B7-42ED-8DB0-E7D84A1BF5DCQ34419089-F8331951-12B2-402C-98FC-27FB7D2C2CA0Q34451886-41ED0E11-737E-43F1-A453-457C3E6BA443Q34471834-006B4D47-206B-42CD-B1F6-9FD511BAC2E8Q34491601-27C53273-9B9E-4AFF-B2C3-7FB8569208DFQ34501432-718DF9CD-1966-4D1A-8156-C0105CE26DDAQ34501742-F2564A2E-4383-489E-8E39-57AF007A5C52Q34514221-457132DF-F81C-4372-A42D-3327B6307483Q34515407-2A59BB1E-6AB6-41AB-BA5E-142BFF1AC7BBQ34540515-92351A3E-3242-43C7-AE47-910E4812F112Q34553148-D315AF8F-960C-4AB9-BDF9-4D09FBE5F5E4Q35057032-7FAB8AC8-3557-4FCD-B727-F3796B1B34ECQ35134053-BFF78CE1-2E9D-4C92-9D86-9586CCECFBBEQ35172366-9A78D795-1856-42DB-AA2A-F331D26E7CFEQ35185931-6276DCA2-4F30-40B1-8E68-2A1506BF3990Q35254099-5A34BCB9-F152-4C08-8E9B-A3EA6FE15EFEQ35584640-0B7FE39A-BC2E-4801-A0A5-13C1A1E13713Q35659920-3CF3F02C-3D6D-405F-B551-0110D3D17662Q35748441-47CBF94F-5D6C-417A-A684-D2AF5AC31739Q35920778-29AB4D5E-9616-4195-89E3-65BFDA7C5B77Q36156667-EB5A5FF8-C073-4443-8682-6FEF96250473Q36335446-B36F499D-D555-4957-B662-04DA8334A5CCQ36385137-8C45B140-5D21-49FE-9F68-5FD41FC2E665Q36653901-8CF5549B-B0C4-44F0-A440-3ACF1BB18AEBQ37052244-6D81093D-16C8-45B6-A5E8-8B411311CD14Q37058585-7BE0A79A-0B18-42C1-A613-40B1097032EFQ37073014-904989CE-68F0-486B-829B-A36292207784
P2860
Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Spice drugs are more than harm ...... logy of synthetic cannabinoids
@ast
Spice drugs are more than harm ...... logy of synthetic cannabinoids
@en
Spice drugs are more than harm ...... logy of synthetic cannabinoids
@nl
type
label
Spice drugs are more than harm ...... logy of synthetic cannabinoids
@ast
Spice drugs are more than harm ...... logy of synthetic cannabinoids
@en
Spice drugs are more than harm ...... logy of synthetic cannabinoids
@nl
prefLabel
Spice drugs are more than harm ...... logy of synthetic cannabinoids
@ast
Spice drugs are more than harm ...... logy of synthetic cannabinoids
@en
Spice drugs are more than harm ...... logy of synthetic cannabinoids
@nl
P2093
P2860
P921
P3181
P1476
Spice drugs are more than harm ...... logy of synthetic cannabinoids
@en
P2093
Jeff Lapoint
Jeffery H. Moran
Kathryn A. Seely
Liana Fattore
P2860
P304
P3181
P356
10.1016/J.PNPBP.2012.04.017
P407
P577
2012-12-03T00:00:00Z